ZW11880A1 - Pyrimidine compounds processes for their preparation pharmaceutical preparations containing these compounds and their use in therapeutics - Google Patents
Pyrimidine compounds processes for their preparation pharmaceutical preparations containing these compounds and their use in therapeuticsInfo
- Publication number
- ZW11880A1 ZW11880A1 ZW118/80A ZW11880A ZW11880A1 ZW 11880 A1 ZW11880 A1 ZW 11880A1 ZW 118/80 A ZW118/80 A ZW 118/80A ZW 11880 A ZW11880 A ZW 11880A ZW 11880 A1 ZW11880 A1 ZW 11880A1
- Authority
- ZW
- Zimbabwe
- Prior art keywords
- compounds
- therapeutics
- pharmaceutical preparations
- preparations containing
- processes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/42—One nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/48—Two nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
- C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH466979 | 1979-05-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZW11880A1 true ZW11880A1 (en) | 1980-12-17 |
Family
ID=4280399
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZW118/80A ZW11880A1 (en) | 1979-05-18 | 1980-05-16 | Pyrimidine compounds processes for their preparation pharmaceutical preparations containing these compounds and their use in therapeutics |
Country Status (21)
| Country | Link |
|---|---|
| EP (1) | EP0019811A1 (en) |
| JP (1) | JPS55154971A (en) |
| KR (1) | KR830002757A (en) |
| AR (1) | AR228256A1 (en) |
| AU (1) | AU5848480A (en) |
| DD (1) | DD150609A5 (en) |
| DK (1) | DK214480A (en) |
| ES (1) | ES491514A0 (en) |
| FI (1) | FI801600A (en) |
| GB (1) | GB2052487B (en) |
| GR (1) | GR68453B (en) |
| IE (1) | IE49803B1 (en) |
| IL (1) | IL60086A (en) |
| MA (1) | MA18829A1 (en) |
| NO (1) | NO801469L (en) |
| NZ (1) | NZ193730A (en) |
| OA (1) | OA06533A (en) |
| PL (1) | PL224313A1 (en) |
| PT (1) | PT71251A (en) |
| ZA (1) | ZA802909B (en) |
| ZW (1) | ZW11880A1 (en) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4507146A (en) * | 1982-12-28 | 1985-03-26 | Ciba-Geigy Corporation | 2,4-Diamino-6-halo-5-trifluoromethylpyrimidines having herbicidal activity |
| DE3829469A1 (en) * | 1988-08-31 | 1990-03-01 | Bayer Ag | METHOD FOR THE PRODUCTION OF SUBSTITUTED N-AZINYL-N'-SULFONYL-ISOTHIO-UREAS AND N-AZINYL-IMINODITHIOCARBONIC ACID-S, S-DIESTER AS INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION |
| CA2269971A1 (en) * | 1997-09-03 | 1999-03-11 | Trent Lee Abraham | Pyrimidine derivatives |
| DE60120193T2 (en) | 2000-09-15 | 2007-03-29 | Vertex Pharmaceuticals Inc., Cambridge | PYRAZOL COMPOUNDS AS PROTEIN KINASE HEMMER |
| US7473691B2 (en) | 2000-09-15 | 2009-01-06 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| US6660731B2 (en) | 2000-09-15 | 2003-12-09 | Vertex Pharmaceuticals Incorporated | Pyrazole compounds useful as protein kinase inhibitors |
| ATE528303T1 (en) | 2000-12-21 | 2011-10-15 | Vertex Pharma | PYRAZOLE COMPOUNDS AS PROTEIN KINASE INHIBITORS |
| SK9562003A3 (en) * | 2001-01-31 | 2004-04-06 | Synaptic Pharma Corp | Use of GAL3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| CA2479036A1 (en) | 2002-03-13 | 2003-09-18 | Euro-Celtique S.A. | Aryl substituted pyrimidines and the use thereof |
| DE60332604D1 (en) | 2002-03-15 | 2010-07-01 | Vertex Pharma | AZOLYLAMINOAZINE AS PROTEIN KINASE INHIBITOR |
| AU2003214110A1 (en) * | 2002-03-15 | 2003-09-29 | Ciba Specialty Chemicals Holding Inc. | 4-aminopyrimidines and their use for the antimicrobial treatment of surfaces |
| MY141867A (en) | 2002-06-20 | 2010-07-16 | Vertex Pharma | Substituted pyrimidines useful as protein kinase inhibitors |
| JP4733388B2 (en) | 2002-08-02 | 2011-07-27 | バーテックス ファーマシューティカルズ インコーポレイテッド | Pyrazole compositions useful as inhibitors of GSK-3 |
| WO2004072029A2 (en) | 2003-02-06 | 2004-08-26 | Vertex Pharmaceuticals Incorporated | Pyrazolopyridazines useful as inhibitors of protein kinases |
| US7737151B2 (en) | 2005-08-18 | 2010-06-15 | Vertex Pharmaceuticals Incorporated | Pyrazine kinase inhibitors |
| CA2627830A1 (en) | 2005-11-03 | 2007-05-18 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as kinase inhibitors |
| JP2010509231A (en) | 2006-11-02 | 2010-03-25 | バーテックス ファーマシューティカルズ インコーポレイテッド | Aminopyridines and aminopyrimidines useful as inhibitors of protein kinases |
| AU2007333650A1 (en) | 2006-12-19 | 2008-06-26 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
| EP2137183B1 (en) | 2007-03-09 | 2011-09-28 | Vertex Pharmaceuticals Incorporated | Aminopyrimidines useful as inhibitors of protein kinases |
| AU2008226461A1 (en) | 2007-03-09 | 2008-09-18 | Vertex Pharmaceuticals Incorporated | Aminopyridines useful as inhibitors of protein kinases |
| ES2435997T3 (en) | 2007-03-09 | 2013-12-26 | Vertex Pharmaceuticals, Inc. | Aminopyrimidines useful as protein kinase inhibitors |
| JP2010523700A (en) | 2007-04-13 | 2010-07-15 | バーテックス ファーマシューティカルズ インコーポレイテッド | Aminopyrimidines useful as kinase inhibitors |
| CA2685876A1 (en) | 2007-05-02 | 2008-11-13 | Vertex Pharmaceuticals Incorporated | Thiazoles and pyrazoles useful as kinase inhibitors |
| CN101801959A (en) | 2007-05-02 | 2010-08-11 | 沃泰克斯药物股份有限公司 | Aminopyrimidines useful as kinase inhibitors |
| CN101790532B (en) | 2007-07-31 | 2013-11-20 | 沃泰克斯药物股份有限公司 | Process for preparing 5-fluoro-1h-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof |
| MX2011002312A (en) | 2008-09-03 | 2011-04-26 | Vertex Pharma | Co-crystals and pharmaceutical formulations comprising the same. |
| ES2623794T3 (en) * | 2008-12-09 | 2017-07-12 | Gilead Sciences, Inc. | Intermediates for the preparation of toll receptor modulators |
| KR102328682B1 (en) * | 2018-08-27 | 2021-11-18 | 주식회사 대웅제약 | Novel heterocyclicamine derivatives and pharmaceutical composition comprising the same |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE754832A (en) * | 1969-08-14 | 1971-02-15 | Beecham Group Ltd | IMINAZOLINES |
-
1980
- 1980-05-05 MA MA19025A patent/MA18829A1/en unknown
- 1980-05-13 DD DD80221082A patent/DD150609A5/en unknown
- 1980-05-14 ES ES491514A patent/ES491514A0/en active Granted
- 1980-05-15 IL IL60086A patent/IL60086A/en unknown
- 1980-05-15 NZ NZ193730A patent/NZ193730A/en unknown
- 1980-05-16 GR GR61963A patent/GR68453B/el unknown
- 1980-05-16 FI FI801600A patent/FI801600A/en not_active Application Discontinuation
- 1980-05-16 AU AU58484/80A patent/AU5848480A/en not_active Abandoned
- 1980-05-16 ZA ZA00802909A patent/ZA802909B/en unknown
- 1980-05-16 ZW ZW118/80A patent/ZW11880A1/en unknown
- 1980-05-16 NO NO801469A patent/NO801469L/en unknown
- 1980-05-16 GB GB8016309A patent/GB2052487B/en not_active Expired
- 1980-05-16 IE IE1023/80A patent/IE49803B1/en unknown
- 1980-05-16 DK DK214480A patent/DK214480A/en not_active Application Discontinuation
- 1980-05-16 EP EP80102724A patent/EP0019811A1/en not_active Withdrawn
- 1980-05-16 PT PT71251A patent/PT71251A/en unknown
- 1980-05-17 JP JP6586380A patent/JPS55154971A/en active Pending
- 1980-05-17 OA OA57113A patent/OA06533A/en unknown
- 1980-05-17 PL PL22431380A patent/PL224313A1/xx unknown
- 1980-05-17 KR KR1019800001944A patent/KR830002757A/en unknown
- 1980-05-19 AR AR281109A patent/AR228256A1/en active
Also Published As
| Publication number | Publication date |
|---|---|
| IE49803B1 (en) | 1985-12-25 |
| PT71251A (en) | 1980-06-01 |
| KR830002757A (en) | 1983-05-30 |
| NZ193730A (en) | 1982-12-21 |
| ES8104279A1 (en) | 1981-04-16 |
| FI801600A (en) | 1980-11-19 |
| AU5848480A (en) | 1980-11-20 |
| GR68453B (en) | 1981-12-30 |
| PL224313A1 (en) | 1981-02-13 |
| EP0019811A1 (en) | 1980-12-10 |
| IL60086A (en) | 1984-03-30 |
| ZA802909B (en) | 1981-05-27 |
| GB2052487A (en) | 1981-01-28 |
| IL60086A0 (en) | 1980-07-31 |
| IE801023L (en) | 1980-11-18 |
| NO801469L (en) | 1980-11-19 |
| DD150609A5 (en) | 1981-09-09 |
| MA18829A1 (en) | 1980-12-31 |
| GB2052487B (en) | 1983-05-11 |
| OA06533A (en) | 1981-07-31 |
| JPS55154971A (en) | 1980-12-02 |
| ES491514A0 (en) | 1981-04-16 |
| DK214480A (en) | 1980-11-19 |
| AR228256A1 (en) | 1983-02-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZW11880A1 (en) | Pyrimidine compounds processes for their preparation pharmaceutical preparations containing these compounds and their use in therapeutics | |
| AU525046B2 (en) | Improvements in and relating to pharmaceutical preparations in solid unit dosage form | |
| DE3067252D1 (en) | Cyclopeptides and pharmaceutical preparations thereof, process for their preparation and their use | |
| MY8700186A (en) | 3-aminopropoxyaryl derivatives their preparation and pharmaceutical compositions containing them | |
| PH20604A (en) | Improvements in or relating to indanyl derivatives and pharmaceutical preparations containing them | |
| PH16228A (en) | Triazolo pyridazine derivatives,pharmaceutical composition containing the same and their use | |
| DE3062310D1 (en) | Pyrimidone derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| GB2095668B (en) | Acylquinolinone derivatives process for their manufacture pharmaceutical preparations containing them and their use | |
| DE3262536D1 (en) | N-dihydrothiazolyl-3-quinoleine carboxyamide derivatives, their salts, their preparation and use as pharmaceutical preparations, and pharmaceutical preparations containing them | |
| ZA803539B (en) | Alkoxybenzylrimidines method for their preparation formulation thereof and their use in medicine | |
| GB2060633B (en) | Isocyanuric acid derivatives preparation and pharmaceutical use thereof | |
| IL59665A0 (en) | Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions | |
| GB2043644B (en) | 3-phosphonocephalosporanic acid derivatives process for preparation thereof and pharmaceutical composition comprising the same | |
| JPS5328133A (en) | Novel compound having lipidddepleting activity in blood*process for preparation thereof and pharmaceutical composition containing these | |
| ZA80922B (en) | Pyrazole derivatives pharmaceutical formulations containing these derivatives and processes for their preparation | |
| IL60325A0 (en) | Novel quinazoline derivatives and pharmaceutical preparations containing them | |
| IL59664A0 (en) | Xanthine derivatives,process for their preparation and their use in pharmaceutical compositions | |
| DE2862102D1 (en) | Pyrimido (4,5-c) pyridazines, their use in pharmaceutical preparations, and process for their preparation | |
| PH16060A (en) | Pyrimidine derivatives and pharmaceutical preparation thereof | |
| ZW15180A1 (en) | Aminothiadiazolyl compounds processes for the manufacture thereof and pharmaceutical preparations containing such compounds and the use thereof | |
| ZA793336B (en) | Novel phenylpiperidine derivatives,processes for their preparation,pharmaceutical preparations containing these derivatives and their use | |
| DE3066533D1 (en) | Optically active cephalosporin analogs, process for their preparation and their use in the preparation of pharmaceutical compositions | |
| NZ184158A (en) | Uracil derivatives: preparation and pharmaceutical preparations | |
| MY8500403A (en) | Ethsanolamine compounds, prolesses for their preparation, pharmaceutical preparations containing them and their medicinal use | |
| DE2861167D1 (en) | 2-amino-thiazoline derivatives, their preparation and their use in pharmaceutical preparations |